Oragenics (OGEN) Inventory Average (2011 - 2016)
Oragenics' (OGEN) quarterly Inventory Average came in at $281495.5 in Q1 2016, down 31.02% YoY from $408102.5 in Q2 2015, and down 9.32% on a QoQ basis from $310412.5 in Q4 2015.
Oragenics (OGEN) Inventory Average (2011 - 2016) Analysis & Trends
Oragenics (OGEN) has 6 years of Inventory Average data on file, last reported at $281495.5 in Q1 2016.
- Quarterly Inventory Average fell 31.02% year-over-year to $281495.5 in Q1 2016, while the trailing twelve-month figure through Mar 2016 was $281495.5 (down 31.02% YoY) and the FY2015 annual result came in at $380349.0, changed 0.22% from the prior year.
- Inventory Average retreated to $281495.5 in Q1 2016, from $310412.5 in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $419288.5 in Q1 2012 to a low of $251417.5 in Q3 2014.
- A 5-year average of $317043.1 and a median of $301638.5 in 2014 frame the typical range for Inventory Average.
- Annual changes were most pronounced in 2015 — Inventory Average surged 46.79% — and 2016, when it plunged 31.02%.
- Tracing OGEN's Inventory Average over 5 years: stood at $419288.5 in 2012, then sank by 35.23% to $271582.0 in 2013, then rose by 29.44% to $351524.5 in 2014, then retreated by 11.7% to $310412.5 in 2015, then declined by 9.32% to $281495.5 in 2016.
- The last three Inventory Average figures came in at $281495.5 (Q1 2016), $310412.5 (Q4 2015), and $331695.0 (Q3 2015), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 90.57 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 196.36 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 137.65 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Oragenics | 2.31 Mn | 2.31 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 281,495.50 |
| Dec 31, 2015 | 310,412.50 |
| Sep 30, 2015 | 331,695.00 |
| Jun 30, 2015 | 370,545.00 |
| Mar 31, 2015 | 408,102.50 |
| Dec 31, 2014 | 351,524.50 |
| Sep 30, 2014 | 251,417.50 |
| Jun 30, 2014 | 252,429.00 |
| Mar 31, 2014 | 292,864.50 |
| Dec 31, 2013 | 271,582.00 |
| Sep 30, 2013 | 263,161.00 |
| Mar 31, 2012 | 419,288.50 |
| Dec 31, 2011 | 470,533.00 |
| Sep 30, 2011 | 483,019.00 |